Tumor-initiating cells arising from prostate intraepithelial neoplasia or glioblastoma have been shown to secrete TN-C to protect themselves from immune surveillance, through an α5β1 or αvβ6 integrin-dependent inhibition of T cell activation and proliferation (65, 66). This evidence concerns the gene TNC and neoplasm.